Kieran, M. W., Sun, Y., Pilarz, C., Calligaris, D., Chadwick, E. J., Alberta, J. A., . . . Buhrlage, S. J. (2016). LG-47 TYPE II RAF INHIBITORS INHIBIT BRAF MUTATIONS AND TRUNCATED FUSIONS IN PEDIATRIC LOW-GRADE GLIOMAS. Neuro Oncol.
Citação norma ChicagoKieran, Mark W., et al. "LG-47 TYPE II RAF INHIBITORS INHIBIT BRAF MUTATIONS AND TRUNCATED FUSIONS IN PEDIATRIC LOW-GRADE GLIOMAS." Neuro Oncol 2016.
Citação norma MLAKieran, Mark W., et al. "LG-47 TYPE II RAF INHIBITORS INHIBIT BRAF MUTATIONS AND TRUNCATED FUSIONS IN PEDIATRIC LOW-GRADE GLIOMAS." Neuro Oncol 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.